EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS

$1,288,760N01FY2007CANIH

Investigators

Charles Erlichmancontact

View original record on NIH RePORTER →

EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS · GrantIndex